CAPECITABINE
Identification of Capecitabine
| No description |
Google image searchProduct monograph
Active ingredient
capecitabine, 150 MG
DIN: 02519879
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 15-JUN-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01B — ANTIMETABOLITES (ATC, ATC/DDD)
- L01BC — Pyrimidine analogues (ATC, ATC/DDD)
- L01BC06 — CAPECITABINE (ATC/DDD)
Reference brand drug: Xeloda
Pharmaceutical standard: USP
